Compile Data Set for Download or QSAR
Report error Found 2619 for UniProtKB: P21462
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050935((S)-2-{(S)-4-Methyl-2-[(S)-4-methylsulfanyl-2-(3-p...)
Affinity DataEC50:  2nMAssay Description:Agonistic activity was determined by measuring the ability to induce superoxide production(as measured by reduction of cytochrome C) using human neut...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050939((S)-2-{(S)-4-Methyl-2-[(S)-4-methylsulfanyl-2-(3-m...)
Affinity DataEC50:  900nMAssay Description:Agonistic activity was determined by measuring the ability to induce superoxide production(as measured by reduction of cytochrome C) using human neut...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050934((S)-2-{(S)-2-[(S)-2-(3-Butyl-ureido)-4-methylsulfa...)
Affinity DataEC50:  300nMAssay Description:Agonistic activity was determined by measuring the ability to induce superoxide production(as measured by reduction of cytochrome C) using human neut...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050941((S)-2-[(S)-4-Methyl-2-((S)-4-methylsulfanyl-2-urei...)
Affinity DataEC50:  3.00E+3nMAssay Description:Agonistic activity was determined by measuring the ability to induce superoxide production(as measured by reduction of cytochrome C) using human neut...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050933((S)-2-((S)-2-{(S)-2-[3-(4-Chloro-phenyl)-ureido]-4...)
Affinity DataEC50:  1nMAssay Description:Agonistic activity was determined by measuring the ability to induce superoxide production(as measured by reduction of cytochrome C) using human neut...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050929(2-((S)-2-{(S)-2-[3-(4-Methoxy-phenyl)-ureido]-4-me...)
Affinity DataEC50:  1nMAssay Description:Agonistic activity was determined by measuring the ability to induce superoxide production(as measured by reduction of cytochrome C) using human neut...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050946((S)-2-{(S)-4-Methyl-2-[(S)-4-methylsulfanyl-2-(3-p...)
Affinity DataEC50:  40nMAssay Description:Agonistic activity was determined by measuring the ability to induce superoxide production(as measured by reduction of cytochrome C) using human neut...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050937(N-formylmethionine-leucine-phenylalanine | (S)-2-[...)
Affinity DataEC50:  20nMAssay Description:Agonistic activity was determined by measuring the ability to induce superoxide production(as measured by reduction of cytochrome C) using human neut...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295520(N-Benzo[1,3]dioxol-5-yl-2-[5-(3-methoxybenzyl)-3-m...)
Affinity DataEC50:  2.30E+3nMAssay Description:Agonist activity at FPR1 in human neutrophiles assessed as induction of intracellular calcium flux by FLIPR3 calcium assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295521(2-[5-(3-Methoxybenzyl)-3-methyl-6-oxo-6H-pyridazin...)
Affinity DataEC50:  5.70E+3nMAssay Description:Agonist activity at FPR1 expressed in human HL60 cells assessed as induction of intracellular calcium flux by FLIPR3 calcium assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295519(N-(3,4-Dimethoxyphenyl)-2-[5-(3-methoxybenzyl)-3-m...)
Affinity DataEC50:  1.55E+4nMAssay Description:Agonist activity at FPR1 expressed in human HL60 cells assessed as induction of intracellular calcium flux by FLIPR3 calcium assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295520(N-Benzo[1,3]dioxol-5-yl-2-[5-(3-methoxybenzyl)-3-m...)
Affinity DataEC50:  3.60E+3nMAssay Description:Agonist activity at FPR1 in human neutrophiles by chemotaxis assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295517(2-[5-(3-Methoxybenzyl)-3-methyl-6-oxo-6H-pyridazin...)
Affinity DataEC50:  7.20E+3nMAssay Description:Agonist activity at FPR1 in human neutrophiles assessed as induction of intracellular calcium flux by FLIPR3 calcium assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295527(2-[5-(3-Methoxybenzyl)-3-methyl-6-oxo-6H-pyridazin...)
Affinity DataEC50:  3.20E+3nMAssay Description:Agonist activity at FPR1 in human neutrophiles by chemotaxis assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295527(2-[5-(3-Methoxybenzyl)-3-methyl-6-oxo-6H-pyridazin...)
Affinity DataEC50:  3.20E+3nMAssay Description:Agonist activity at FPR1 in human neutrophiles by chemotaxis assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295517(2-[5-(3-Methoxybenzyl)-3-methyl-6-oxo-6H-pyridazin...)
Affinity DataEC50:  1.60E+3nMAssay Description:Agonist activity at FPR1 in human neutrophiles assessed as induction of intracellular calcium flux by FLIPR3 calcium assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295517(2-[5-(3-Methoxybenzyl)-3-methyl-6-oxo-6H-pyridazin...)
Affinity DataEC50:  1.60E+3nMAssay Description:Agonist activity at FPR1 in human neutrophiles by chemotaxis assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295514(N-(4-Chlorophenyl)-2-[5-(3-methoxybenzyl)-3-methyl...)
Affinity DataEC50:  6.70E+3nMAssay Description:Agonist activity at FPR1 in human neutrophiles by chemotaxis assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295520(N-Benzo[1,3]dioxol-5-yl-2-[5-(3-methoxybenzyl)-3-m...)
Affinity DataEC50:  3.60E+3nMAssay Description:Agonist activity at FPR1 in human neutrophiles assessed as induction of intracellular calcium flux by FLIPR3 calcium assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295519(N-(3,4-Dimethoxyphenyl)-2-[5-(3-methoxybenzyl)-3-m...)
Affinity DataEC50:  3.60E+3nMAssay Description:Agonist activity at FPR1 in human neutrophiles assessed as induction of intracellular calcium flux by FLIPR3 calcium assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295515(N-(4-Iodophenyl)-2-[5-(3-methoxybenzyl)-3-methyl-6...)
Affinity DataEC50:  3.20E+3nMAssay Description:Agonist activity at FPR1 in human neutrophiles by chemotaxis assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295525(N-(4-Bromophenyl)-3-[3-(3-methoxybenzyl)-5-methyl-...)
Affinity DataEC50:  1.13E+4nMAssay Description:Agonist activity at FPR1 in human neutrophiles assessed as induction of intracellular calcium flux by FLIPR3 calcium assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295523(N-(4-Bromophenyl)-2-[5-(4-methoxybenzyl)-3-methyl-...)
Affinity DataEC50:  4.30E+3nMAssay Description:Agonist activity at FPR1 in human neutrophiles assessed as induction of intracellular calcium flux by FLIPR3 calcium assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295526(N-(4-Bromophenyl)-2-[5-(3-methoxybenzyl)-3-methyl-...)
Affinity DataEC50:  3.20E+3nMAssay Description:Agonist activity at FPR1 expressed in human HL60 cells assessed as induction of intracellular calcium flux by FLIPR3 calcium assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295521(2-[5-(3-Methoxybenzyl)-3-methyl-6-oxo-6H-pyridazin...)
Affinity DataEC50:  2.17E+4nMAssay Description:Agonist activity at FPR1 in human neutrophiles assessed as induction of intracellular calcium flux by FLIPR3 calcium assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295518(2-[5-(3-Methoxybenzyl)-3-methyl-6-oxo-6H-pyridazin...)
Affinity DataEC50:  1.10E+3nMAssay Description:Agonist activity at FPR1 in human neutrophiles assessed as induction of intracellular calcium flux by FLIPR3 calcium assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295524(N-(4-Bromophenyl)-2-[5-(3-methoxybenzyl)-3-methyl-...)
Affinity DataEC50:  2.60E+3nMAssay Description:Agonist activity at FPR1 in human neutrophiles assessed as induction of intracellular calcium flux by FLIPR3 calcium assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295516(N-(4-Fluorophenyl)-2-[5-(3-methoxybenzyl)-3-methyl...)
Affinity DataEC50:  7.60E+3nMAssay Description:Agonist activity at FPR1 in human neutrophiles assessed as induction of intracellular calcium flux by FLIPR3 calcium assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295526(N-(4-Bromophenyl)-2-[5-(3-methoxybenzyl)-3-methyl-...)
Affinity DataEC50:  800nMAssay Description:Agonist activity at FPR1 in human neutrophiles assessed as induction of intracellular calcium flux by FLIPR3 calcium assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295524(N-(4-Bromophenyl)-2-[5-(3-methoxybenzyl)-3-methyl-...)
Affinity DataEC50:  2.60E+3nMAssay Description:Agonist activity at FPR1 in human neutrophiles by chemotaxis assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295521(2-[5-(3-Methoxybenzyl)-3-methyl-6-oxo-6H-pyridazin...)
Affinity DataEC50:  2.17E+4nMAssay Description:Agonist activity at FPR1 in human neutrophiles by chemotaxis assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295519(N-(3,4-Dimethoxyphenyl)-2-[5-(3-methoxybenzyl)-3-m...)
Affinity DataEC50:  3.60E+3nMAssay Description:Agonist activity at FPR1 in human neutrophiles by chemotaxis assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050937(N-formylmethionine-leucine-phenylalanine | (S)-2-[...)
Affinity DataEC50:  10nMAssay Description:Agonist activity at FPR1 in human neutrophiles assessed as induction of intracellular calcium flux by FLIPR3 calcium assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295522(2-[5-(3-Methoxybenzyl)-3-methyl-6-oxo-6H-pyridazin...)
Affinity DataEC50:  1.05E+4nMAssay Description:Agonist activity at FPR1 in human neutrophiles assessed as induction of intracellular calcium flux by FLIPR3 calcium assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295526(N-(4-Bromophenyl)-2-[5-(3-methoxybenzyl)-3-methyl-...)
Affinity DataEC50:  800nMAssay Description:Agonist activity at FPR1 in human neutrophiles by chemotaxis assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295524(N-(4-Bromophenyl)-2-[5-(3-methoxybenzyl)-3-methyl-...)
Affinity DataEC50:  3.40E+3nMAssay Description:Agonist activity at FPR1 expressed in human HL60 cells assessed as induction of intracellular calcium flux by FLIPR3 calcium assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295514(N-(4-Chlorophenyl)-2-[5-(3-methoxybenzyl)-3-methyl...)
Affinity DataEC50:  6.70E+3nMAssay Description:Agonist activity at FPR1 in human neutrophiles assessed as induction of intracellular calcium flux by FLIPR3 calcium assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295514(N-(4-Chlorophenyl)-2-[5-(3-methoxybenzyl)-3-methyl...)
Affinity DataEC50:  2.60E+3nMAssay Description:Agonist activity at FPR1 expressed in human HL60 cells assessed as induction of intracellular calcium flux by FLIPR3 calcium assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295516(N-(4-Fluorophenyl)-2-[5-(3-methoxybenzyl)-3-methyl...)
Affinity DataEC50:  3.90E+3nMAssay Description:Agonist activity at FPR1 in human neutrophiles by chemotaxis assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295525(N-(4-Bromophenyl)-3-[3-(3-methoxybenzyl)-5-methyl-...)
Affinity DataEC50:  9.70E+3nMAssay Description:Agonist activity at FPR1 expressed in human HL60 cells assessed as induction of intracellular calcium flux by FLIPR3 calcium assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295515(N-(4-Iodophenyl)-2-[5-(3-methoxybenzyl)-3-methyl-6...)
Affinity DataEC50:  2.80E+3nMAssay Description:Agonist activity at FPR1 expressed in human HL60 cells assessed as induction of intracellular calcium flux by FLIPR3 calcium assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295515(N-(4-Iodophenyl)-2-[5-(3-methoxybenzyl)-3-methyl-6...)
Affinity DataEC50:  3.20E+3nMAssay Description:Agonist activity at FPR1 in human neutrophiles assessed as induction of intracellular calcium flux by FLIPR3 calcium assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295513((S)-6-amino-2-((S)-2-amino-3-(1H-indol-3-yl)propan...)
Affinity DataEC50:  500nMAssay Description:Agonist activity at FPR1 in human neutrophiles assessed as induction of intracellular calcium flux by FLIPR3 calcium assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295523(N-(4-Bromophenyl)-2-[5-(4-methoxybenzyl)-3-methyl-...)
Affinity DataEC50:  4.30E+3nMAssay Description:Agonist activity at FPR1 in human neutrophiles by chemotaxis assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295525(N-(4-Bromophenyl)-3-[3-(3-methoxybenzyl)-5-methyl-...)
Affinity DataEC50:  1.13E+4nMAssay Description:Agonist activity at FPR1 in human neutrophiles by chemotaxis assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295516(N-(4-Fluorophenyl)-2-[5-(3-methoxybenzyl)-3-methyl...)
Affinity DataEC50:  3.90E+3nMAssay Description:Agonist activity at FPR1 in human neutrophiles assessed as induction of intracellular calcium flux by FLIPR3 calcium assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295518(2-[5-(3-Methoxybenzyl)-3-methyl-6-oxo-6H-pyridazin...)
Affinity DataEC50:  7.70E+3nMAssay Description:Agonist activity at FPR1 expressed in human HL60 cells assessed as induction of intracellular calcium flux by FLIPR3 calcium assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50295518(2-[5-(3-Methoxybenzyl)-3-methyl-6-oxo-6H-pyridazin...)
Affinity DataEC50:  1.10E+3nMAssay Description:Agonist activity at FPR1 in human neutrophiles by chemotaxis assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50051609(CHEMBL3311301)
Affinity DataKd:  6.90nMAssay Description:Antagonist activity at formyl peptide receptor in human HL60 cells assessed as inhibition of intracellular calcium mobilization incubated for 5 mins ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50051610(CHEMBL3311300)
Affinity DataKd:  2.10nMAssay Description:Antagonist activity at formyl peptide receptor in human HL60 cells assessed as inhibition of intracellular calcium mobilization incubated for 5 mins ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
Displayed 1 to 50 (of 2619 total ) | Next | Last >>
Jump to: